FDA Unfairly ‘Maligning’ Responsible CBD Product Marketers – Council For Responsible Nutrition

 
• By Eileen Francis

Dietary supplement trade groups reacted on 26 November – in CRN’s case with umbrage – to the US Food and Drug Administration’s latest barrage of cannabidiol (CBD)-themed warning letters and accompanying update to consumers regarding CBD safety.

Building icon with inscription FDA and flag of The United States over abstract background. - Illustration

More from Regulation

More from Policy & Regulation